Pelthos Therapeutics Inc. (PTHS) Earnings History
Annual and quarterly earnings data from 2022 to 2024
Loading earnings history...
PTHS EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PTHS Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
Download Data
Export PTHS earnings history in CSV or JSON format
Free sign-in required to download data
Pelthos Therapeutics Inc. (PTHS) Earnings Overview
As of May 8, 2026, Pelthos Therapeutics Inc. (PTHS) reported trailing twelve-month net income of -$24M, reflecting -5.8% year-over-year growth. The company earned $-36.82 per diluted share over the past four quarters.
Looking at the long-term picture, PTHS's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2022.
Pelthos Therapeutics Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including COLL ($75M net income, 8.1% margin), AVDL (-$278,000 net income, -28.9% margin), SUPN (-$29M net income, -5.4% margin), PTHS has comparable earnings metrics. Compare PTHS vs COLL →
PTHS Earnings vs Peers
Earnings metrics vs comparable public companies
PTHS Historical Earnings Data (2022–2024)
3 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$8M | -7.8% | -$8M | $-13.54 | - | - |
| 2023 | -$7M | -200.2% | -$7M | $-12.80 | - | - |
| 2022 | -$2M | - | -$2M | $-4.26 | - | - |
See PTHS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PTHS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PTHS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPTHS — Frequently Asked Questions
Quick answers to the most common questions about buying PTHS stock.
Is PTHS growing earnings?
PTHS EPS fell to $-36.82, with earnings declining -5.8%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-24M.
What are PTHS's profit margins?
Pelthos Therapeutics Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are PTHS's earnings?
PTHS earnings data spans 2022-2024. The declining earnings trend is -5.8% YoY. Historical data enables comparison across business cycles.